Alzheimer’s drug lecanemab slows cognitive decline among patients in early stages study finds – USA TODAY

A study released Tuesday showed a closely-watched Alzheimer’s drug slowed cognitive decline among people with early signs of the disease but also carries safety risks for some patients.
The peer-rev… [read more]

Leave a Reply